Bellevue Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.2M | Sell |
|
|||||
|
2025
Q1 | $43M | Sell |
|
|||||
|
2024
Q4 | $66.6M | Buy |
|
|||||
|
2024
Q3 | $107M | Buy |
|
|||||
|
2024
Q2 | $186M | Sell |
|
|||||
|
2024
Q1 | $182M | Sell |
|
|||||
|
2023
Q4 | $190M | Buy |
|
|||||
|
2023
Q3 | $154M | Sell |
|
|||||
|
2023
Q2 | $185M | Sell |
|
|||||
|
2023
Q1 | $238M | Sell |
|
|||||
|
2022
Q4 | $284M | Buy |
|
|||||
|
2022
Q3 | $184M | Sell |
|
|||||
|
2022
Q2 | $225M | Sell |
|
|||||
|
2022
Q1 | $282M | Sell |
|
|||||
|
2021
Q4 | $434M | Sell |
|
|||||
|
2021
Q3 | $665M | Sell |
|
|||||
|
2021
Q2 | $597M | Sell |
|
|||||
|
2021
Q1 | $368M | Sell |
|
|||||
|
2020
Q4 | $308M | Sell |
|
|||||
|
2020
Q3 | $236M | Sell |
|
|||||
|
2020
Q2 | $215M | Sell |
|
|||||
|
2020
Q1 | $118M | Sell |
|
|||||
|
2019
Q4 | $96.5M | Buy |
|
|||||
|
2019
Q3 | $77.1M | Buy |
|
|||||
|
2019
Q2 | $69.2M | Buy |
|